IPP Bureau
Evonik partners with Safic-Alcan to boost offering of advanced food ingredients
By IPP Bureau - May 11, 2023
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
FSD Pharma completes dosing of first cohort in Phase I clinical trial of Lucid-MS
By IPP Bureau - May 11, 2023
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
Lupin posts Q4FY23 consolidated PAT up at Rs. 235.96 Cr
By IPP Bureau - May 10, 2023
The company has reported total income of Rs. 4467.35 crores during the quarter ended March 31, 2023
Venus Remedies bolsters its position in oncology space with marketing approval from Philippines, Iraq
By IPP Bureau - May 10, 2023
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
Cigniti bags ‘Best IoT Healthcare Platform’ award in 2023
By IPP Bureau - May 10, 2023
The Awards recognizes standout digital health & medical technology products and companies
Boehringer Ingelheim begins clinical development for fibrotic diseases
By IPP Bureau - May 10, 2023
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Zion Pharma inks agreement with Roche to develop and commercialize brain-penetrable compounds
By IPP Bureau - May 10, 2023
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market
By IPP Bureau - May 09, 2023
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Baxter to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion
By IPP Bureau - May 09, 2023
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Briefs: Krsnaa Diagnostics
By IPP Bureau - May 09, 2023
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana
By IPP Bureau - May 09, 2023
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Formosa Pharmaceuticals and AimMax Therapeutics announce NDA Submission to USFDA for APP13007
By IPP Bureau - May 08, 2023
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Galmed Pharmaceuticals forms partnership with OnKai
By IPP Bureau - May 08, 2023
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Wacker acquires Spain-based biotech firm ADL BioPharma
By IPP Bureau - May 08, 2023
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
Lupin to acquire French pharmaceutical company Medisol
By IPP Bureau - May 07, 2023
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
